Tidal Investments’s Day One Biopharmaceuticals DAWN Stock Holding History

Tidal Investments’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-32,074	Closed	-$688K	–	2664
2026 Q1	$688K	Buy	+32,074	New	+$452K	﹤0.01%	1687

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tidal Investments's DAWN Position: Q2 2026 in Review

Tidal Investments sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 32,074 shares — an estimated $688K sold.

Tidal Investments first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $688K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Tidal Investments reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Tidal Investments sold 32,074 Day One Biopharmaceuticals shares in Q2 2026, an estimated $688K.
Tidal Investments first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Tidal Investments's Day One Biopharmaceuticals position peaked at $688K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.